New Jersey says 3 chemical makers agree to 'forever chemical' settlement worth up to $2 billion
State Environmental Commissioner Shawn LaTourette said the deal with DuPont, Chemours and Corteva is the largest such settlement in the state's history. It calls for the companies to pay $875 million over 25 years and create a remediation fund of up $1.2 billion. The companies will split the costs under the deal, which must still be approved by the courts.
PFAS, or perfluoroalkyl and polyfluoroalkyl substances, are a group of chemicals that have been around for decades and have now spread into the nation's air, water and soil. They are commonly referred to as 'forever chemicals.'
DuPont said the settlement will resolve 'all pending environmental and other claims' for 'legacy" contamination claims at four sites where the companies operated in the state. It comes just months after the state said chemical manufacturer 3M has agreed to pay up $450 million to resolve lawsuits over natural resource contamination stemming from PFAS.
"Polluters who place profit above public well-being by releasing poisonous PFAS and other contamination in our State can expect to be held responsible to clean up their mess and fully compensate the State and its citizens for the precious natural resources they've damaged or destroyed," LaTourette said.
PFAS were manufactured by companies such as 3M, Chemours and others because they were incredibly useful. They helped eggs slide across non-stick frying pans, ensured that firefighting foam suffocates flames and helped clothes withstand rain and keep people dry.
The chemicals resist breaking down, though, meaning they linger in the environment.
Environmental activists say PFAS makers knew about the health harms of PFAS long before they were made public. The same attributes that make the chemicals so valuable – resistance to breakdown – make them hazardous to people.
PFAS accumulate in the body, which is why the Environmental Protection Agency set their limits for drinking water at 4 parts per trillion for two common types — PFOA and PFOS — that are phased out of manufacturing but still are present in the environment.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CBS News
3 days ago
- CBS News
Chemours must immediately stop unlawfully polluting Ohio River, federal judge orders
A federal judge ordered the Chemours Chemical Company on Thursday to immediately stop discharging unlawful levels of cancer-causing chemicals into the Ohio River from the company's Washington Works plant in West Virginia. "Those pollutants endanger the environment, aquatic life, and human health," U.S. District Judge Joseph R. Goodwin wrote in the order. "Today, that unlawful, unpermitted discharge stops." The West Virginia Rivers Coalition asked Goodwin in February to require the former DuPont, now Chemours, Washington Works facility to immediately comply with its permit limits after violating it for more than five years. The coalition's request came after the group initially sued Chemours in December over the violations. In Thursday's order, Goodwin wrote that the Chemours' Washington Works facility "boldly violates" its permit, and must meet its permit limits until the full case is heard later this year. "(Chemours) knows that it has been violating its permit, and it is likely to continue," Goodwin wrote. "As a direct result, the public is exposed to real and ongoing harm." Since 2019, the Washington Works site has violated its permit limits by discharging higher than allowed levels of pollution, including PFAS, or 'forever chemicals,' into the Ohio River, which supplies drinking water for more than five million people. Exposure to these chemicals has been linked to several serious health conditions, including cancer, liver and kidney damage, developmental problems and immune system disorders. Such chemicals — which resist heat, water, oil and grease — are used to produce everyday items, including nonstick pots and pans. Chemours has acknowledged the plant has violated its permit limits. But they argue that they are working with the U.S. Environmental Protection Agency to address the issues. The federal agency issued a 2023 order to require the company to address its violations, but Chemours still hasn't submitted a plan the EPA will approve. In May, the EPA was reviewing an updated plan the company submitted in April. "We are disappointed in the court's ruling, strongly disagree with its characterizations, and plan to appeal the decision," Chemours spokesperson Jess Loizeaux wrote in an email. Loizeaux said that Washington Works' PFAS discharges have decreased in recent months and the company looks to "maintain this compliance as we continue to implement abatement actions and take other steps at the plant." The West Virginia Rivers Coalition did not immediately respond to requests for comment. "The present circumstance is that individuals who live on and engage with the Ohio River face a terrible choice: abstain from using or drinking water that comes from the Ohio River or subject themselves to the adverse health effects associated with toxic pollutants," Goodwin wrote. "This choice violates the law." ___ This story was originally published by Mountain State Spotlight and distributed through a partnership with The Associated Press.
Associated Press
3 days ago
- Associated Press
Chemours must immediately stop unlawfully polluting Ohio River, federal judge orders
A federal judge ordered the Chemours Chemical Company on Thursday to immediately stop discharging unlawful levels of cancer-causing chemicals into the Ohio River from the company's Washington Works plant in West Virginia. 'Those pollutants endanger the environment, aquatic life, and human health,' U.S. District Judge Joseph R. Goodwin wrote in the order. 'Today, that unlawful, unpermitted discharge stops.' The West Virginia Rivers Coalition asked Goodwin in February to require the former DuPont, now Chemours, Washington Works facility to immediately comply with its permit limits after violating it for more than five years. The coalition's request came after the group initially sued Chemours in December over the violations. In Thursday's order, Goodwin wrote that the Chemours' Washington Works facility 'boldly violates' its permit, and must meet its permit limits until the full case is heard later this year. '(Chemours) knows that it has been violating its permit, and it is likely to continue,' Goodwin wrote. 'As a direct result, the public is exposed to real and ongoing harm.' Since 2019, the Washington Works site has violated its permit limits by discharging higher than allowed levels of pollution, including PFAS, or 'forever chemicals,' into the Ohio River, which supplies drinking water for more than five million people. Exposure to these chemicals has been linked to several serious health conditions, including cancer, liver and kidney damage, developmental problems and immune system disorders. Such chemicals — which resist heat, water, oil and grease — are used to produce everyday items, including nonstick pots and pans. Chemours has acknowledged the plant has violated its permit limits. But they argue that they are working with the U.S. Environmental Protection Agency to address the issues. The federal agency issued a 2023 order to require the company to address its violations, but Chemours still hasn't submitted a plan the EPA will approve. In May, the EPA was reviewing an updated plan the company submitted in April. 'We are disappointed in the court's ruling, strongly disagree with its characterizations, and plan to appeal the decision,' Chemours spokesperson Jess Loizeaux wrote in an email. Loizeaux said that Washington Works' PFAS discharges have decreased in recent months and the company looks to 'maintain this compliance as we continue to implement abatement actions and take other steps at the plant.' The West Virginia Rivers Coalition did not immediately respond to requests for comment. 'The present circumstance is that individuals who live on and engage with the Ohio River face a terrible choice: abstain from using or drinking water that comes from the Ohio River or subject themselves to the adverse health effects associated with toxic pollutants,' Goodwin wrote. 'This choice violates the law.' ___ This story was originally published by Mountain State Spotlight and distributed through a partnership with The Associated Press.
Yahoo
4 days ago
- Yahoo
Why DuPont Stock Topped the Market on Tuesday
Key Points The company beat the consensus analyst estimates for both revenue and profitability in its second quarter. It also raised guidance, hence the positive investor reaction. 10 stocks we like better than DuPont de Nemours › On the back of a beat-and-raise second quarter, storied chemical company DuPont (NYSE: DD) saw a satisfying share price rise on Tuesday. The company's stock became more than 2% more valuable that trading session as the market digested its results. That increase was particularly impressive when matched against the S&P 500 index's 0.5% slide on the day. Two beats in quarter two DuPont's earnings release, published before market open, revealed that the company's revenue for the period was $3.26 billion. That was 3% higher than that of the same quarter last year. It was also high enough -- albeit barely -- to edge past the consensus $3.24 billion analyst estimate. Within its sprawling product assortment, DuPont saw particularly robust growth in its electronics segment, which saw a 6% rise in sales. As for regional performance, the Asia Pacific region led with a 4% increase, followed by 2% in Europe, the Middle East and Africa, and 1% in North America. On the bottom line, non-GAAP (adjusted) net income cranked quite a bit higher. It came in at $468 million, or $1.12 per share; this was nearly 15% above the year-ago profit. It also represented a more convincing beat for DuPont, as the collective pundit forecast was $1.06 per share. In the earnings release, DuPont quoted CEO Lori Koch as saying that "Ongoing strength in electronics, healthcare and water end-markets, along with our team's focus on operational execution continued to drive strong earnings growth and cash conversion." Annual bottom-line boost With those tailwinds, DuPont is clearly feeling bullish about the future. It raised its full-year guidance for adjusted net income, which is now anticipated to ring in at around $4.40 per share. That should derive from roughly $12.85 billion in net sales. Should you buy stock in DuPont de Nemours right now? Before you buy stock in DuPont de Nemours, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and DuPont de Nemours wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $631,505!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,103,313!* Now, it's worth noting Stock Advisor's total average return is 1,039% — a market-crushing outperformance compared to 181% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of August 4, 2025 Eric Volkman has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. Why DuPont Stock Topped the Market on Tuesday was originally published by The Motley Fool Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
